Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 60 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Georgianos, Panagiotis I  [Clear All Filters]
2019
Georgianos, P. I., Vaios V., Leontaridou E., Karayannopoulou G., Koletsa T., Sioulis A., et al. (2019).  Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab.. Case Rep Nephrol. 2019, 3614980.
Vaios, V., Georgianos P. I., Liakopoulos V., & Agarwal, iv R. (2019).  Assessment and Management of Hypertension among Patients on Peritoneal Dialysis.. Clin J Am Soc Nephrol. 14(2), 297-305.
Vaios, V., Georgianos P. I., Vareta G., Dounousi E., Dimitriadis C., Eleftheriadis T., et al. (2019).  Clinic and Home Blood Pressure Monitoring for the Detection of Ambulatory Hypertension Among Patients on Peritoneal Dialysis.. Hypertension. 74(4), 998-1004.
Georgianou, E., Georgianos P. I., Petidis K., Markakis K., Zografou I., & Karagiannis A. (2019).  Effect of Nebivolol and Olmesartan on 24-Hour Brachial and Aortic Blood Pressure in the Acute Stage of Ischemic Stroke.. Int J Hypertens. 2019, 9830295.
Georgianos, P. I., Liakopoulos V., & Zebekakis P. E. (2019).  Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions.. J Clin Hypertens (Greenwich). 21(2), 249-251.
Georgianos, P. I., Zebekakis P. E., & Liakopoulos V. (2019).  Optimal diastolic blood pressure range in intensive systolic targets: Resolving the controversy between observational and intention-to-treat analyses.. J Clin Hypertens (Greenwich). 21(7), 919-921.
Georgianos, P. I., Divani M., Eleftheriadis T., Mertens P. R., & Liakopoulos V. (2019).  SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?. Curr Med Chem. 26(29), 5564-5578.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.